X
Access Company Profiles

Get business overview, business operations details specific to this market, products and services, latest developments and more...

Business Email

Select Companies

 

Enzyme-Linked Immunosorbent Assay Companies

This report lists the top Enzyme-Linked Immunosorbent Assay companies based on the 2023 & 2024 market share reports. Mordor Intelligence expert advisors conducted extensive research and identified these brands to be the leaders in the Enzyme-Linked Immunosorbent Assay industry.

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Enzyme-Linked Immunosorbent Assay Top Companies

  1. Thermo Fisher Scientific

  2. Bio-Rad Laboratories

  3. Agilent Technologies

  4. Merck

  5. Promega

*Disclaimer: Top companies sorted in no particular order

Enzyme-Linked Immunosorbent Assay Market Major Players

Enzyme-Linked Immunosorbent Assay Market Concentration

Enzyme-Linked Immunosorbent Assay  Market Concentration

Enzyme-Linked Immunosorbent Assay Company List

                            • Thermo Fisher Scientific

                            • Abcam Plc

                            • Merck KGaA

                            • Bio-Rad Laboratories, Inc

                            • Cell Biolabs, Inc

                            • Promega Corporation

                            • Zeus Scientific, Inc

                            • Enzo-lifesciences, Inc

                            • Arbor Assays, Inc

                            • Biolegend, Inc

                            • Agilient Technologies, Inc

                            • J. Mitra & Co. Pvt Ltd


                        Specific to Enzyme-Linked Immunosorbent Assay Market
                        Need More Details On Market Players And Competitors?
                        Download PDF

                        Enzyme-Linked Immunosorbent Assay (ELISA) Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)